Please note the new changes affecting all CTIMP applications are submitted from 1 January 2022. Combined review offers a single application route and co-ordinated review leading to a single UK decision for Clinical Trials of Investigational Medicinal Products (CTIMPs).

For more information, please see here.

The NIHR King's Wellcome Clinical Research Facility (CRF) complies with Good Clinical Practice (GCP), Good Manufacturing Practice (GMP) and all relevant specific regulatory requirements and legislation.

The CRF is a facility for researchers from:

The CRF works closely with the following departments:

The CRF has different approval and governance requirements depending on whether a study involves patients or healthy volunteers/non-NHS subjects.

The SLaM/IoPPN R&D department or KCH R&I department can provide further information on approval requirements (eg: HRA Approval) and sponsorship.

The flowchart below summarises the requirements for all studies which are to be conducted in the CRF:

Please contact Elka Giemza, CRF Manager, if you have any questions about our governance requirements.